Let's Find Opportunities Overseas
Tag: ValueInvesting
📦 The Yellow Fortress Arbitrage: Inside MercadoLibre's $2B Cash Blast, Melamud's Double Buy, and the 49% Hyper-Growth Squeeze
MercadoLibre continues building one of the world's most impressive digital ecosystems. Revenue grew 49%, operating cash flow doubled to $2.07 billion, insiders bought shares, and institutions own nearly 89% of the float. Is MELI still worth buying after its latest rally?
🇧🇷 Banco Bradesco (BBD): A 5–6% Dividend, a $2 Million Insider Buy, and Why This Brazilian Bank May Be Too Cheap to Ignore
Banco Bradesco won't be mistaken for a high-flying AI stock—and that's precisely why it deserves attention. With improving earnings, a healthy dividend, insider buying, and a reasonable valuation, one of Brazil's largest banks may quietly reward patient long-term investors.
🇧🇷 StoneCo (STNE): An 8× Forward P/E, a CFO Insider Buy, and Why This Brazilian FinTech May Be Too Cheap to Ignore
StoneCo has quietly rebuilt profitability after one of the toughest periods in its history. Trading at only about 8× forward earnings while generating robust cash flow and a 24% return on equity, the Brazilian fintech presents a fascinating question: has the market become too pessimistic about Brazil?
🌏 Alibaba (BABA): Cheap for a Reason… or the Comeback of the Decade? 🐉📈
Alibaba (BABA) is back in the spotlight. Founder buying, strong AI momentum, and a discounted valuation are colliding with geopolitical risks and declining cash flow. Is this a rare opportunity—or a well-disguised value trap?
Why Sensata’s CEO Is Buying This Overlooked Sensor Stock
Is ST a hidden value gem… or a cyclical value trap in disguise? NYSE: ST — $34.01 (-$0.58, -1.68%) as of Mar. 18, 2026, 4:10 PM ET 🎯 FunStock Index™ : 7.9 / 10 🎯 Tooltip: A cash-generating, mission-critical sensor company with real value credentials, real cyclicality, and just enough transformation juice to keep things interesting. Not a moonshot. More like a quietly loaded toolbox. Sensata Technologies is one of those companies most investors barely notice—until they realize its products are buried inside the machines that keep the modern world from acting like a drunk Roomba. The company makes sensors, electrical protection components, battery-management solutions, contactors, switches, relays, and other mission-critical parts used across autos, industrial systems, aerospace, defense, and...
Can Carrefour Replace Checkout Lines with Bull Runs? Investors Hope So
Carrefour (CRRFY) isn’t just where you grab cheese, wine, and a pack of discount batteries. It’s a global grocery titan with 11,000+ stores, strong free cash flow, a 7% dividend yield, and bold bets in Latin America. But is it a shopper’s delight—or just another cart with a wobbly wheel?
Teva Pharma: The Funds Believe. Should You?
Hedge fund legend Stanley Druckenmiller just upped his stake in TEVA by 65%—and he’s not alone. With 9 straight quarters of growth, rising biosimilar momentum, and a “Pivot to Growth” strategy in motion, Teva might finally be ready for its rerating. We still like the sandals, but the stock may be worth more than a hike.
Coupang (CPNG): Another $37 Million Says... This E-Commerce Giant Isn’t Done Yet
Insiders and hedge funds are piling into Coupang (CPNG)—the Amazon of South Korea—but is it a smart buy or just an expensive gamble? With soaring revenue, strong growth in Eats, Play, and Fintech, and no debt, the company looks solid. But with thin margins, political unrest, and a sky-high P/E of 290, is the stock's future as promising as it seems? 🤔🚀